Trial Profile
Obervational, prospective study to evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in Taiwan
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2007
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Psychotic disorders
- Focus Therapeutic Use
- Sponsors Genovate Biotechnology
- 19 Oct 2007 New trial record.